SSE: 603998
Notice on Convening the 2nd Extraordinary General Meeting in 2026The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
(603998)"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Notice on Convening the 2nd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
View original source (Shanghai Stock Exchange)
Earlier from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A
- "HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Progress of Transfer of Certain Equity Interests in a Controlled Subsidiary and Introduction of Strategic Investors
- "HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- "HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Outline of the 2026 Semi-annual Performance and Cash Dividend Briefing
- "HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Election of Employee Directors and Adjustment of the Remuneration and Appraisal Committee Members